Anika Therapeutics Inc. (ANIK): Kapitalisasi marang pendapatan

Simbol lan logo merek Anika (ANIK)

Anika Therapeutics relies on unique joint-preserving injections, which provide the company with a competitive market advantage. Business efficiency is supported by outsourced manufacturing and global logistics. However, insurance reimbursement limits are constraining pricing power. P/S volatility confirms these fundamental aspects, and 1.50 expresses the metric's value today, capturing the current investor consensus on revenue valuation.

ANIK Multiplikator P/S Anika (04.07.2022 - 16.11.2026)

Rincian analitis perusahaan Anika Therapeutics Inc. (ANIK)

Analisis umum perusahaan:ANIK Anika Therapeutics
Barang utama Anika Therapeutics, Inc.

Investors are assessing the resilience of Anika Therapeutics (ANIK) through the market capitalization-to-annual revenue ratio, which determines the value of each dollar of sales. By analyzing the price-to-sales multiple history, one can understand how effectively the medical device component outsourcing model converts into market value, avoiding overpaying for the asset during periods of unjustified price peaks.

Pesaing Anika Therapeutics

Kapitalisasi marang pendapatan Boston Scientific Corporation BSX|Multiplikator P/S EW (Edwards Lifesciences)|ResMed Corp (RMD) - Rega marang dodolan|Insulet Corp - Multiplikator P/S|ZBH (zimmerbiomet.com) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (NuVasive) - Multiplikator P/S|TransMedics Corp (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion, Inc. AORT|Multiplikator P/S ENOV (enovis.com)|Multiplikator P/S Integra LifeSciences Corp IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (IRADIMED CORPORATION) - Kapitalisasi marang pendapatan|Embecta Corp. - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Corp) - Multiplikator P/S|Rega marang dodolan AxoGen Inc AXGN|Rasio rega marang pendapatan SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Multiplikator rega marang pendapatan|Multiplikator P/S BVS (bioventus.com)|Multiplikator P/S OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Multiplikator P/S|Koefisien rega marang pendapatan Blade Air Mobility SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Ophthalmic)|Rasio rega marang pendapatan clearpointneuro.com|Kapitalisasi marang pendapatan Stereotaxis, Inc. (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical Inc - Kapitalisasi marang volume dodolan|XTNT (Xtant Medical Holdings) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan NMTC|Rasio rega marang pendapatan Modular Medical Inc|Rega marang dodolan Myomo Inc MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc.)|Rasio rega marang pendapatan VVOS (vivoslife.com)|enVVeno Medical Corp. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan SINT (sintx.com)|TNON - Rasio rega marang pendapatan|LFWD: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - Multiplikator P/S|Axonics Modulation Technologies (AXNX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BIOL (Biolase, Inc.)|Dynatronics - Rasio kapitalisasi marang pendapatan|Paragon 28, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan INVO Bio (INVO)